MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H+ Transporting V1 Subunit C1
Open Access
- 13 February 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (4) , 796
Abstract
Activated hepatic stellate cells (aHSCs) play a key role in liver fibrosis. During the regression of fibrosis, aHSCs are transformed into inactivated cells (iHSCs), which are quiescent lipid-containing cells and express higher levels of lipid-related genes, such as peroxisome proliferators-activated receptors gamma (PPARγ). Here, we investigated the role of MicroRNA29a (Mir29a) in the resolution of liver fibrosis. Mir29a and lipid-related genes were up-regulated after the recovery of CCl4-induced liver fibrosis in mice. PPARγ agonist rosiglitazone (RSG) promoted de-differentiation of aHSCs to iHSCs and up-regulated MIR29a expression in a human HSC cell line LX-2. MIR29a mimics in vitro promoted the expression of lipid-related genes, while decreased the expression of fibrosis-related genes. MIR29a inhibitor showed the reverse effects. ATPase H+ transporting V1 subunit C1 (Atp6v1c1) was increased in liver fibrosis, while down-regulated after the recovery in mice, and negatively regulated by MIR29a in LX-2 cells. Knockdown of ATP6V1C1 by siRNA decreased alpha-smooth muscle actin (α-SMA) and increased lipid-related genes expression. Simultaneous addition of MIR29a mimics and ATP6V1C1 siRNA further increased RSG promoted expression of lipid-related proteins in vitro. Collectively, MIR29a plays an important role during the trans-differentiation of aHSCs in the resolution of liver fibrosis, in part, through regulation of ATP6V1C1.Keywords
Funding Information
- National Natural Science Foundation of China (31771514)
- China Postdoctoral Science Foundation (2018M640455)
- National first-class discipline program of Light Industry Technology and Engineering (LITE2018-11)
- the Six Talent Peaks Project in Jiangsu Province (2015-SWYY-006)
- Fundamental Research Funds for the Central Universities (1102050205181880, JUSRP21824)
This publication has 41 references indexed in Scilit:
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in MiceGastroenterology, 2012
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisProceedings of the National Academy of Sciences, 2012
- Protective Role of Estrogen-induced miRNA-29 Expression in Carbon Tetrachloride-induced Mouse Liver InjuryJournal of Biological Chemistry, 2012
- Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in RatsGastroenterology, 2012
- Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in CultureThe Journal of Infectious Diseases, 2011
- Scraping fibrosis: Expressway to the core of fibrosisNature Medicine, 2011
- Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung developmentProceedings of the National Academy of Sciences, 2011
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008
- MicroRNA biogenesis: coordinated cropping and dicingNature Reviews Molecular Cell Biology, 2005